You are here

Article info

Article menu
Download PDFPDF
Editorial
Early stopping of a randomised trial for efficacy: a medical, ethical and regulatory challenge

Authors

  • Arthur Darmon FACT (French Alliance for Cardiovascular Trials), DHU-FIRE, Hopital Bichat-Claude Bernard, Paris, France Université de Paris, Assistance Publique—Hôpitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Gregory Ducrocq FACT (French Alliance for Cardiovascular Trials), DHU-FIRE, Hopital Bichat-Claude Bernard, Paris, France Université de Paris, Assistance Publique—Hôpitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Arthur Darmon, Department of Cardiology, Assistance Publique - Hopitaux de Paris, 75004 Paris, France; arthur.darmon{at}gmail.com
View Full Text

Citation

Darmon A, Ducrocq G
Early stopping of a randomised trial for efficacy: a medical, ethical and regulatory challenge
Heart 2021;107:1109-1110.

Publication history

  • First published May 21, 2021.
Online issue publication 
June 25, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.